STRATA Skin Sciences Balans Gezondheid
Financiële gezondheid criteriumcontroles 3/6
STRATA Skin Sciences has a total shareholder equity of $9.5M and total debt of $15.1M, which brings its debt-to-equity ratio to 159.2%. Its total assets and total liabilities are $39.6M and $30.1M respectively.
Belangrijke informatie
159.2%
Verhouding schuld/eigen vermogen
US$15.11m
Schuld
| Rente dekkingsratio | n/a |
| Contant | US$5.48m |
| Aandelen | US$9.50m |
| Totaal verplichtingen | US$30.09m |
| Totaal activa | US$39.58m |
Recente financiële gezondheidsupdates
Is STRATA Skin Sciences (NASDAQ:SSKN) Weighed On By Its Debt Load?
Aug 07
Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt In A Risky Way?
Mar 19Health Check: How Prudently Does STRATA Skin Sciences (NASDAQ:SSKN) Use Debt?
Nov 03We Think STRATA Skin Sciences (NASDAQ:SSKN) Has A Fair Chunk Of Debt
Jul 04Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt Sensibly?
Jan 14Recent updates
Investors Don't See Light At End Of STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Tunnel And Push Stock Down 30%
Aug 18Is STRATA Skin Sciences (NASDAQ:SSKN) Weighed On By Its Debt Load?
Aug 07STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Shares Lagging The Industry But So Is The Business
Jun 07Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt In A Risky Way?
Mar 19STRATA Skin Sciences, Inc.'s (NASDAQ:SSKN) Price Is Right But Growth Is Lacking After Shares Rocket 25%
Dec 31Health Check: How Prudently Does STRATA Skin Sciences (NASDAQ:SSKN) Use Debt?
Nov 03We Think STRATA Skin Sciences (NASDAQ:SSKN) Has A Fair Chunk Of Debt
Jul 04STRATA Skin Sciences, Inc. (NASDAQ:SSKN) Stock Rockets 26% But Many Are Still Ignoring The Company
Apr 18Is STRATA Skin Sciences (NASDAQ:SSKN) Using Debt Sensibly?
Jan 14STRATA Skin Sciences GAAP EPS of -$0.05 in-line, revenue of $9.1M beats by $0.96M
Aug 10Strata Skin stock soars ~18% after hours on U.S. commercial launch of acne treatment
Jul 25What Type Of Returns Would STRATA Skin Sciences'(NASDAQ:SSKN) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Mar 09Reflecting on STRATA Skin Sciences' (NASDAQ:SSKN) Share Price Returns Over The Last Five Years
Nov 24
STRATA Skin Sciences EPS in-line, beats on revenue
Nov 10Analyse van de financiële positie
Kortlopende schulden: SSKN's short term assets ($13.8M) exceed its short term liabilities ($12.1M).
Langlopende schulden: SSKN's short term assets ($13.8M) do not cover its long term liabilities ($18.0M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: SSKN's net debt to equity ratio (101.4%) is considered high.
Schuld verminderen: SSKN's debt to equity ratio has increased from 25.3% to 159.2% over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: SSKN has sufficient cash runway for more than a year based on its current free cash flow.
Voorspelling contante baan: SSKN has sufficient cash runway for 1.1 years if free cash flow continues to reduce at historical rates of 54.3% each year.